Back to Journals

Neuropsychiatric Disease and Treatment


Aims and Scope

Editor-in-Chief: Dr Roger M Pinder

Neuropsychiatric Disease and Treatment is an international, peer reviewed, open access journal publishing on all aspects of neuropsychiatric and neurological disorders. The journal is characterized by the rapid reporting of new and emerging clinical or pre-clinical studies, pharmacology and therapeutic strategies to overcome a wide range of conditions as well as the diagnosis, prognosis, epidemiology and genetic associations of these diseases.

Topics covered in this journal include: 

  • Biological basis and clinical treatment of Neuropsychiatric conditions such as Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorders, Anxiety and Depressive Disorders, Bipolar Disorders and Schizophrenia
  • Biological basis and clinical treatment of Neurological conditions such as Dementia, Parkinson’s Disease, Epilepsy, Multiple Sclerosis, Migraines, Strokes
  • Research on the normal brain which gives insight into potential dysfunction, disease or the mechanisms of treatments

The journal welcomes submitted papers covering original research, reviews and evaluations, guidelines, expert opinion and commentary, and extended reports.

Case reports submitted to Neuropsychiatric Disease and Treatment will be diverted to the Neuropsychiatric Disease and Treatment section of the International Medical Case Reports Journal.

When considering submission of a paper utilizing publicly available data, authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors’ own data through replication in an original sample.

As of 1st April 2019, Neuropsychiatric Disease and Treatment will no longer consider meta-analyses for publication.